Antibiotic Resistance Market Increasing Demand By Disease, Pathogen, Drug Class, and Forecast Period 2021 - 2028

Acumen Research and Consulting has announced the addition of the "Antibiotic Resistance Market” report to their offering.

The Antibiotic Resistance Market Report 2018 is an in depth study analyzing the current state of the Antibiotic Resistance Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Antibiotic Resistance Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Antibiotic Resistance Market also discusses the opportunity areas for investors.

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Download Sample Report Copy From Here: https://www.acumenresearchandconsulting.com/request-sample/933

Market Players as below:

Some of the key players include TPfizer, Merck, Allergan, The Medicines Company, Melinta Therapeutics, Phage Technologies S.A, Tetraphase Pharmaceuticals, Nabriva Therapeutics. Macrolide Pharmaceuticals, Nemesis Bioscience, Westway Health, AmpliPhi Biosciences  and BioVersys GmbH. Industry participant battle on the basis of price, new innovated product launch, and expanding market presence.

The major market segments of Antibiotic Resistance Market are as below:

Market By Disease

• Complicated Urinary Tract Infection (cUTI)
• Complicated Intra-Abdominal Infections (cIAI)
• Blood Stream Infections (BSI)
• Clostridium difficile infections (CDI)
• Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
• Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)         
• Community Acquired Bacterial Pneumonia (CABP)

Market By Pathogen

• Acinetobacter baumannii (Carbapenem-Resistant and ESBL-producing)
• Pseudomonas aeruginosa (Carbapenem-Resistant)
• Staphylococcus Aureus (Methicillin-Resistant)
• E. coli/K. pneumoniae (Carbapenem-Resistant)
• Streptococcus pneumoniae (Penicillin-Non-Susceptible)
• Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant)
• Enterococcus faecium (Vancomycin-Resistant)
• Haemophilus Influenzae (Ampicillin-Resistant)

Market By Drug Class

• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Cephalosporins
• Combination therapies
• Others

Market By Geography

North America
•    U.S.
•    Canada

Europe
•    U.K.
•    Germany
•    France
•    Spain
•    Rest of Europe

Asia-Pacific
•    China
•    Japan
•    India
•    Australia
•    South Korea
•    Rest of Asia-Pacific

Latin America
•    Brazil 
•    Mexico
•    Rest of Latin America

Middle East & Africa
•    GCC
•    South Africa
•    Rest of Middle East & Africa

Ask Query Here: frank@acumenresearchandconsulting.com  or sales@acumenresearchandconsulting.com

Table Of Contents@ https://www.acumenresearchandconsulting.com/table-of-content/antibiotic-resistance-market

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/933

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.